A short-term high fat diet increases exposure to midazolam and omeprazole in healthy subjects

Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):715-20. doi: 10.1080/17425255.2016.1192126. Epub 2016 Jun 3.

Abstract

Objectives: Knowledge of factors contributing to variation in drug metabolism is of vital importance to optimize drug treatment. This study assesses the effects of a short-term hypercaloric high fat diet on metabolism of five oral drugs, which are each specific for a single P450 isoform: midazolam (CYP3A4), omeprazole (CYP2C19), metoprolol (CYP2D6), S-warfarin (CYP2C9) and caffeine (CYP1A2).

Methods: In 9 healthy volunteers, pharmacokinetics of the five drugs were assessed after an overnight fast at two separate occasions: after a regular diet and after 3 days of a hypercaloric high fat diet (i.e. regular diet supplemented with 500 mL cream [1715 kcal, 35% fat]). Pharmacokinetic parameters (mean [SEM]) were estimated by non-compartmental analysis.

Results: The high fat diet increased exposure to midazolam by 19% from 24.7 (2.6) to 29.5 (3.6) ng ml-1h-1 (p=0.04) and exposure to omeprazole by 31% from 726 (104) to 951 (168) ng ml-1h-1 (p=0.05). Exposure to metoprolol, caffeine and S-warfarin was not affected by the high fat diet.

Conclusion: A short-term hypercaloric high fat diet increases exposure to midazolam and omeprazole, possibly reflecting modulation of CYP3A4 and CYP2C19.

Keywords: Cytochrome P450; drug metabolism and pharmacokinetics; high fat diet; nutrition.

MeSH terms

  • Adult
  • Cross-Over Studies
  • Cytochrome P-450 CYP2C19 / metabolism
  • Cytochrome P-450 CYP3A / metabolism
  • Cytochrome P-450 Enzyme System / metabolism*
  • Diet, High-Fat*
  • Humans
  • Male
  • Midazolam / administration & dosage
  • Midazolam / pharmacokinetics*
  • Omeprazole / administration & dosage
  • Omeprazole / pharmacokinetics*
  • Young Adult

Substances

  • Cytochrome P-450 Enzyme System
  • Cytochrome P-450 CYP2C19
  • Cytochrome P-450 CYP3A
  • Omeprazole
  • Midazolam